ApprovalTrail

Approval · Notice of Compliance 2003 · 1999

PONDOCILLIN: Notice of Compliance 2003

Issued January 25, 1999

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2003
Date
January 25, 1999
Company
Leo Laboratories Ltd.Aylesbury, Buckinghamshire, United Kingdom
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product monograph update
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
PONDOCILLINNot yet assigned—

Medicinal ingredients